Full-Time
Nurse Practitioner or Physician Assistant Oncology
Confirmed live in the last 24 hours
The Oncology Institute of Hope and Innovation
201-500 employees
Specialized community-based cancer care provider
Compensation Overview
$120k - $140.8k/yr
Mid
Riverside, CA, USA
- Master's degree in nursing
- Possession of current certificate of completion from a Nurse Practitioner or Physician Assistant program
- Current and unrestricted license to practice
- National Certification required upon employment (Nurse Practitioners)
- Ensure patient information, visit history, refer outs, lab follow-up, phone calls, and consults are carefully and completely documented in the electronic medical record.
- Conducts in-depth interviews with patients and/or family, constructs comprehensive medical histories, performs initial and periodic physical examinations and explores patient's interpretation of health needs. Identifies and treats patients' diseases.
- Directly performs or orders appropriate diagnostic studies and interprets finished results.
- Develops and implements long and short-range treatment plans.
- Performs procedures such as bone marrow biopsy.
- Instructs and counsels patients and families regarding preventive care, medical problems, psychological problems, and use of prescribed treatments and drugs.
- Writes orders to increase, decrease or change medication, subject to checking and countersigning by physician.
- Identifies and records pertinent progress of patients, updating and summarizing charts, changing orders when appropriate and notifying the responsible physician of changes in the patient's condition.
- Will need hospital privileges to assist with call.
- Oncology experience preferred but not required.
The Oncology Institute of Hope and Innovation (TOI) provides specialized cancer care focused on value and accessibility in community settings. Their services include clinical trials, transfusions, and various care delivery models that are typically found in advanced healthcare organizations. TOI serves over 1.7 million patients through a network of 50 clinics and employs more than 90 clinicians and 700 staff members. What sets TOI apart from its competitors is its commitment to delivering evidence-based care directly within the community, making advanced cancer treatments more accessible. The goal of TOI is to improve the quality of oncology care and outcomes for patients by providing comprehensive services tailored to their needs.
Company Size
201-500
Company Stage
IPO
Headquarters
Cerritos, California
Founded
2007
Simplify's Take
What believers are saying
- TOI's $16.5M funding supports organic growth and working capital needs.
- The acquisition of SRON strengthens TOI's radiation oncology presence in Los Angeles.
- TOI's AI partnership with Massive Bio enhances cancer care and research capabilities.
What critics are saying
- Increased competition in Florida may impact TOI's market share and profitability.
- Operational challenges with House Rx could affect patient access and satisfaction.
- Integration issues with SRON may disrupt services in Greater Los Angeles.
What makes The Oncology Institute of Hope and Innovation unique
- TOI's High-Value Cancer Care model reduces costs and hospitalizations effectively.
- The Florida Oncology Network expands TOI's reach with a fully delegated cancer care network.
- TOI's partnership with House Rx enhances pharmacy operations and patient access to medications.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Flexible Work Hours
Hybrid Work Options
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 0%2 year growth
↑ 1%CERRITOS, Calif., May 08, 2025 (GLOBE NEWSWIRE) - The Oncology Institute, Inc. (NASDAQ: TOI)("TOI"), one of the largest value-based oncology groups in the United States, announced today that it has been selected to present an abstract at the upcoming ASCO Annual Meeting further validating cost savings and reduced hospitalizations associated with its unique High-Value Cancer Care (HVCC) model*.
CERRITOS, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today proudly announced the launch of the Florida Oncology Network. This new fully delegated network will expand access to high-quality, coordinated cancer care for Florida residents.The Florida Oncology Network includes TOI Clinics and a robust panel of value-focused medical and radiation oncologists strategically located throughout the state. The network is designed to provide comprehensive cancer care that is accessible, affordable, and focused on outcomes for patients and payor partners.Under the delegated arrangement, TOI has partnered with Provider Network Solutions (PNS), the market leader in specialty MSO and third-party administrative services, and through its affiliates will provide claims administration and processing as well as network management. The collaboration brings together TOI’s nationally recognized clinical model and PNS’s deep experience supporting delegated provider networks in Florida. Together, the organizations will focus on improving patient outcomes, reducing unnecessary variation in care, and aligning incentives with value-based objectives.The Florida Oncology Network commences operations effective immediately, with plans to grow both its geographic footprint and patient reach across Florida throughout 2025
The Oncology Institute (NASDAQ: TOI) has secured a $16.5 million private placement from accredited investors, including existing investors, management, and Board Directors, expected to close on March 26, 2025. The placement involves units priced at $2.2084, consisting of two common stock shares and warrants. Deerfield Management will exchange $4.1 million of TOI's convertible notes for preferred shares and warrants. Proceeds will support organic growth and working capital needs.
Toi Management, LLCCERRITOS, Calif., Oct. 11, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) has announced the appointment of Jeremy Castle, MBA, as Chief Operations Officer, effective September 5, 2023. In this role, Mr. Castle leads enterprise field and central operations, pharmacy, real estate, and practice integration, playing a key role in driving TOI’s success as a public company.Mr. Castle joins TOI with over 15 years of oncology industry experience, and has a track record of driving growth and profitability for multi-state physician groups
SAN FRANCISCO, July 31, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute (NASDAQ: TOI) and House Rx announced today that they have entered into a multi-year relationship that will integrate House Rx’s specialty medication dispensing model to operate and manage TOI’s clinic and pharmacy locations in multiple markets.House Rx provides clinics with specialized technology and services support from pharmacists and care coordinators. House Rx staff are integrated with the clinic to help patients start therapy as quickly as possible and drive adherence to treatment for better outcomes.TOI’s alignment with House Rx will expand patient access to oral specialty medications via TOI dispensary and pharmacy locations, and enhance in-office dispensary operations. The relationship will further enable TOI to provide convenient and affordable access to value-based therapies for patients as part of its comprehensive community-based care model.“By partnering with House Rx, we will accelerate the growth of our clinic-based oral drug dispensing capabilities and improve our ability to add pharmacy locations in California and Texas that will allow us to access patient populations that we previously could not serve,” said Dr. Daniel Virnich, CEO of The Oncology Institute. “We see this as one of the key drivers of our growth in upcoming years.”"With TOI, we have an innovative partner that cares deeply about delivering value-based care in the community setting," said Tesh Khullar, President and Co-Founder of House Rx. "By adopting our dispensing services and technology, TOI will strengthen their value-based care offering by ensuring more patients can access their specialty medications and receive the best possible outcomes from their treatments.”About The Oncology Institute, Inc.Founded in 2007, TOI is advancing oncology by delivering highly specialized, value-based cancer care in the community setting